Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
187.21
+0.15 (+0.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
59
60
Next >
If You Invested $100 In This Stock 15 Years Ago, You Would Have $500 Today
↗
April 26, 2023
Via
Benzinga
Biogen Earnings Perspective: Return On Capital Employed
↗
April 26, 2023
Via
Benzinga
Alphabet To Rally Around 36%? Here Are 10 Other Analyst Forecasts For Wednesday
↗
April 26, 2023
Morgan Stanley raised the price target for Alphabet Inc. (NASDAQ: GOOGL) from $135 to $140. Morgan Stanley analyst Brian Nowak maintained an Overweight rating. Alphabet shares fell 1% to $102.83 in...
Via
Benzinga
These Analysts Revise Price Targets On Biogen Following Q1 Results
↗
April 26, 2023
Biogen Inc. (NASDAQ: BIIB) reported results for its first quarter.
Via
Benzinga
FDA Grants Accelerated Approval for QALSODY™ (tofersen) for SOD1-ALS, a Major Scientific Advancement as the First Treatment to Target a Genetic Cause of ALS
April 25, 2023
From
Biogen Inc.
Via
GlobeNewswire
Biogen On The Hunt
↗
April 25, 2023
Biogen is in the process of culling its pipeline to prepare for its upcoming deal making. What is happening and what does it mena?
Via
Talk Markets
Earnings Outlook For Biogen
↗
April 24, 2023
Via
Benzinga
What Does Biogen's Debt Look Like?
↗
April 19, 2023
Via
Benzinga
What's Going On With Biogen Stock Tuesday?
↗
April 25, 2023
Biogen Inc (NASDAQ: BIIB) shares are trading lower Tuesday. The company reported first-quarter results before the bell and the FDA approved its ALS therapy Tuesday afternoon.
Via
Benzinga
Biogen Inc. Beats Q1 Earnings And Revenue Estimates
↗
April 25, 2023
Biogen Inc. came out with quarterly earnings of $3.40 per share.
Via
Talk Markets
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
↗
April 25, 2023
Via
Benzinga
Alzheimer's Drugs Still Aren't Biogen's Saving Grace — But The Company Is Hopeful
↗
April 25, 2023
The company is hopeful for maintenance dosing and a new injection of the drug.
Via
Investor's Business Daily
3 Top Biotech Stocks Defying the Bear Market
↗
April 25, 2023
All three companies have therapies with strong sales potential.
Via
The Motley Fool
Why Legend Biotech Stock Is Having Its Best Month Yet
April 25, 2023
With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high.
Via
MarketBeat
P/E Ratio Insights for Biogen
↗
April 19, 2023
Via
Benzinga
Is Biogen Stock a Buy Now?
↗
April 18, 2023
The company's fascinating saga in the Alzheimer's disease drug market continues.
Via
The Motley Fool
Leqembi Sales To Propel Biogen Stock To New Heights, Says Bullish Analyst
↗
April 17, 2023
Via
Benzinga
Why Shares of Keros Therapeutics Jumped This Week
↗
April 21, 2023
The company appointed a new director and an analyst reiterated his position on the stock.
Via
The Motley Fool
Biogen To Report Q1 Earnings: Here's What To Expect
↗
April 21, 2023
We expect Biogen to beat expectations when it reports first-quarter 2023 results on Apr. 25 before the market opens. In the last reported quarter, the company delivered an earnings surprise of 15.38%.
Via
Talk Markets
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
↗
April 21, 2023
Eli Lilly And Co (NYSE: LLY) expects the U.S. Medicare health plan to loosen its grip on the coverage limits on new Alzheimer's drugs, as more data emerging in coming weeks show that clearing amyloid...
Via
Benzinga
Better Big Biotech Buy: Biogen vs. Vertex
↗
April 20, 2023
One is slightly cheaper than the other.
Via
The Motley Fool
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
↗
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
Biogen Earnings Conference Call Is Coming Up, Here's What You Need To Know
↗
April 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 17, 2023
↗
April 17, 2023
Via
Benzinga
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
↗
April 16, 2023
Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.
Via
InvestorPlace
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
↗
April 16, 2023
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.
Via
InvestorPlace
Biogen Moves Deeper In Alzheimer's With Denali
↗
April 14, 2023
Biogen exercised their rights to a Denali Alzheimer's drug. What does this mean longer term to the field and the companies?
Via
Talk Markets
The Unexpected Way The Texas Abortion Ruling Could Destroy Biotech
↗
April 14, 2023
One executive called this the most "damaging" decision in five decades.
Via
Investor's Business Daily
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
↗
April 12, 2023
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this...
Via
Benzinga
Biogen Exercises Option with Denali to Develop and Commercialize Antibody Transport Vehicle Program Targeting Amyloid Beta
April 12, 2023
Program uses Denali’s Antibody Transport Vehicle (ATV) technology to cross the blood-brain barrier (BBB) and aims to increase target engagement
From
Denali Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
59
60
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
